No high level evidence to support the use of oral H1 antihistamines as monotherapy for eczema: a summary of a Cochrane systematic review

URN zum Zitieren dieses Dokuments: urn:nbn:de:bvb:355-epub-296265

Zuuren, Esther J. van, Apfelbacher, Christian J., Fedorowicz, Zbys, Jupiter, Aldrin, Matterne, Uwe und Weisshaar, Elke (2014) No high level evidence to support the use of oral H1 antihistamines as monotherapy for eczema: a summary of a Cochrane systematic review. Systematic Reviews 3 (25).

Vorschau

PDF Download (314kB)

Zum Artikel beim Verlag (über DOI)

Andere URL zum Volltext: http://www.systematicreviewsjournal.com/content/3/1/25

Zusammenfassung

Background The most important symptom as well as one of the major diagnostic criteria for eczema is itch. Although oral antihistamines continue to be prescribed for people with eczema, it is unclear if they are effective and safe in relieving itch and skin lesions. We sought to evaluate the available evidence on effectiveness of oral antihistamines (H1 antagonists) as monotherapy in children ...

Bibliographische Daten exportieren